Hong Kong Software Stock News

The recent approval of InnoCare Pharma (SEHK:9969)’s IND application for ICP-B381 by China’s drug regulator gives investors a new clinical asset to watch in the company’s antibody drug conjugate pipeline. That IND approval landed after a strong run in InnoCare Pharma’s share price, with a 90-day share price return of 42.66% and a year-to-date share price gain of 22.80%, even though the 1-year total shareholder return declined 12.59% and the 5-year total shareholder return fell 25.67%. Scan...

Tencent has recently been ranked among the top three most influential brands in Asia and has secured new partnerships in esports, AI education, and gaming infrastructure across the region. These moves show Tencent pushing deeper into higher value services such as cloud based esports systems, university level AI training, and open source game engine support, which could influence long term monetization and ecosystem depth. We will now assess how Tencent's broader push into esports...

Insiders who acquired HK$5.33m worth of LIT Life Holdings Limited's ( HKG:8079 ) stock at an average price of HK$0.64...

China Medical System Holdings (SEHK:867) has drawn fresh attention after two product milestones in China. CMS-D001 secured regulatory clearance to begin lupus trials, while Silevimig Injection entered large-scale clinical use for rabies. For context, China Medical System Holdings’ share price has slipped over the year to HK$11.13, with a year-to-date share price return of down 15.10%. However, the 90-day share price return of 9.44% points to some recent momentum as investors weigh these...

Those following along with SSY Group Limited ( HKG:2005 ) will no doubt be intrigued by the recent purchase of shares...

Insiders who bought HK$10.9m worth of Unity Enterprise Holdings Limited ( HKG:2195 ) stock in the last year recovered...

In September 2026, Meituan showcased AI agents for individuals, merchants, and enterprises, including its Smart Shopkeeper tool that structures customer reviews and provides targeted operational suggestions. The scale of AI driven logistics on display, with ZTO Express operating more than 3,500 unmanned delivery vehicles across over 260 cities, highlights how automation is starting to reshape last mile capacity and service quality for Meituan's ecosystem partners. We will now examine how...

HBM Holdings released its H1 2026 earnings on 13 September 2026, updating investors on the group’s operating performance and financial position for the first half of the year. Management commentary during the earnings call provided additional detail on how current cost pressures and demand conditions are affecting HBM Holdings’ core businesses. This article examines how HBM Holdings’ investment narrative could be influenced by the new information on first half operating performance. Compare...

As Asian markets navigate a landscape marked by fluctuating energy prices and evolving monetary policies, investors are increasingly seeking opportunities in stocks that might be undervalued relative to their intrinsic worth. In this context, identifying stocks that are trading below their estimated fair value can offer potential for growth, particularly as regional economies continue to adapt to global economic shifts.

Cathay Pacific Airways (SEHK:293) has given investors fresh data to chew on after publishing unaudited traffic figures for August 2026. The update details passenger volumes, cargo activity, and load factors across both Cathay Pacific and HK Express. At a share price of HK$14.13, Cathay Pacific Airways has logged an 18.64% 90-day share price return and an 11.88% year-to-date share price gain. The 1-year total shareholder return of 45.36% and 5-year total shareholder return of 169.66% highlight...

Why Ascentage Pharma Group International Is Back On Investor Radars Ascentage Pharma Group International (SEHK:6855) has moved into focus after agreeing to a research collaboration in hematologic oncology with Peking University, tying its cancer pipeline more closely to academic and clinical resources. At a HK$31.7 share price, Ascentage Pharma Group International has seen a sharp 1-day share price return of 7.24%, which contrasts with a weaker year-to-date share price return. The 1-year...

Sun Hung Kai Properties reported full year 2026 sales of HK$94,194 million and net income of HK$21,426 million, alongside a proposed final dividend of HK$2.93 per share for approval at the November 2026 AGM. The proposed dividend, slightly above the prior year’s HK$2.80 per share, reflects management’s stated confidence in cash generation and long term capital return discipline. We will examine how Sun Hung Kai Properties' investment narrative is influenced by reported earnings and the...

Nexteer Automotive Group was removed from the FTSE All-World Index in September 2026, a benchmark tracked by a wide range of global investors. This index exit can affect how much Nexteer Automotive Group features in passive portfolios, which matters for liquidity, ownership mix, and how management thinks about capital markets access. We will now assess how Nexteer Automotive Group's index removal could reshape the existing investment narrative built around electrification and by-wire...

Brilliance China Automotive Holdings was removed from the FTSE All-World Index after the latest review, an index change that occurred before 21 September 2026 and directly affects its inclusion in many global equity benchmarks. This exit from a widely tracked index can matter for Brilliance China Automotive Holdings because passive funds linked to that benchmark may need to rebalance, which can influence liquidity and the investor mix around the stock. We will now look at how Brilliance...

Crystal International Group reported stronger interim profit and an interim dividend for the first half of 2026, supported by healthier apparel demand and tighter operational controls. The business has also strengthened its internal processes after a factoring disclosure lapse, which may influence how investors view its earnings quality and risk controls. This article explores how Crystal International Group's investment narrative is shaped by stronger interim profitability and higher...

Hansoh Pharmaceutical Group reported that HS-10374, its self-developed selective TYK2 inhibitor, met co-primary and multiple secondary endpoints in a pivotal Phase III trial in adults with moderate-to-severe plaque psoriasis. The trial showed higher PASI 75 and sPGA 0/1 response rates than placebo, no new safety signals, and the company now plans to prepare a new drug application in China. The psoriasis data indicate that HS-10374 could extend Hansoh Pharmaceutical Group's reach into chronic...

Yangtze Optical Fibre And Cable Joint Stock Limited Company approved an interim dividend of RMB 10.60 per 10 shares for the first half of 2026, totaling about RMB 877,579,414, with H share holders generally receiving HKD 12.26 per 10 shares based on a fixed exchange rate calculation. The detailed dividend structure, including currency conversion terms and a defined entitlement date, highlights how Yangtze Optical Fibre And Cable manages capital returns between domestic and H share...

China Coal Energy (SEHK:1898) came back into focus after its September 11 update showed lower year on year commercial coal and self produced coal volumes, while several chemical product lines reported higher monthly and year to date tonnages. Recent trading shows that China Coal Energy’s share price has drifted over the past month and quarter, with a 30 day share price return of 3.22% lower and a 90 day share price return of 1.19% lower. This comes even as the year to date share price return...

China Power International Development entered into a multi year Framework Agreement with State Power Investment Corporation Limited Group in September 2026 to supply environmental protection engineering services and related products, with proposed annual caps of RMB 700,000,000 for late 2026 and RMB 1,450,000,000 for 2027 and 2028. The agreement formalizes a broad service scope from coal fired plant upgrades to carbon capture projects. This indicates that environmental services are becoming...

Industrial and Commercial Bank of China (SEHK:1398) just wrapped up a RMB 20b issuance of undated Additional Tier 1 capital bonds, giving the lender fresh regulatory capital and added financial flexibility. The fresh Additional Tier 1 capital comes as Industrial and Commercial Bank of China’s HK$7.58 share price sits on a year to date share price return of 19.56%, with a 90 day share price gain of 8.91% and a 1 year total shareholder return of 39.24%. This hints that investors have been...

XTransfer’s new cooperation with China Zheshang Bank (SEHK:2016) on all currency settlement and minor currency collection puts cross border payment plumbing at center stage for anyone tracking the stock. The cooperation lands while China Zheshang Bank’s 30 day share price return of 6.78% and 90 day share price return of 6.09% point to improving short term momentum, even though the year to date share price return declined 3.56% and the 1 year total shareholder return declined 1.48%. This...

Genscript Biotech announced that it joined Eli Lilly's TuneLab AI-enabled drug discovery platform, agreeing to provide preferred-rate wet lab services that turn AI predictions into biological data, in line with its integrated R&D support strategy. The TuneLab agreement embeds Genscript Biotech directly into AI-driven discovery workflows, which could influence future demand, capacity planning, and pricing power across its lab services portfolio. We will now assess how Genscript Biotech's...

Vobile Group officially launched the SeeBay platform on 17 September 2026, positioning it as a one stop hub for AI content creation and global IP monetization, with over 20,000 registered users and more than 13,600 content creation tasks recorded so far. The collaboration agreement between a Vobile Group subsidiary and Ant Blockchain Technology to build a copyright large model signals a push to hardwire IP protection and rights management into AI driven content workflows. This development...

Index Exit Puts United Energy Group in Focus United Energy Group (SEHK:467) has been removed from the FTSE All-World Index in its USD version, an index change that can affect passive fund flows and institutional visibility. United Energy Group’s HK$0.42 share price has moved higher over the past month, with a 30-day share price return of 9.09% and a 90-day gain of 16.67%. However, the year-to-date share price return is down 10.64% and the 1-year total shareholder return has fallen 22.22%...